GET THE APP

Seroprevalence of Chikungunya Virus from a Tertiary Care Hospital of Central India-A Major Public Health Problem

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research - (2021) Volume 9, Issue 10

Seroprevalence of Chikungunya Virus from a Tertiary Care Hospital of Central India-A Major Public Health Problem

Suneel Kumar*

*Correspondence: Suneel Kumar, MGM Medical College, India, Email:

Author info »

Abstract

Introduction: Chikungunya (CHIK) fever is a viral disease characterized by abrupt onset of fever with severe arthralgia followed by constitutional symptoms including rash. The disease is re-emerging in various parts of the Southeast Asia including India. This study aimed at determining the seroprevalence of acute infections of chikungunya virus in central India. Objective: to find the seroprevalence of chikungunya in suspected cases. Materials and Methods: This retrospective study was conducted in a department of Microbiology MGM Medical College and M.Y. Hospital, Indore from January 2017 to December 2017. All serum samples were received with details patients, clinical finding and were tested for CHIK Immunoglobin M (IgM) antibodies by enzyme-linked immunosorbent assay. Results: A total of 245 serum samples from suspected cases of chikungunya infection were received during the period from January 2017 to December 2017, out of which 188 (76.7%) samples were positive for CHIK. Conclusion: Chikungunya virus appears to be actively circulating in the population. Need for continuous surveillance for disease burden using multiple diagnostic tests and also warrants the need for an appropriate molecular diagnostic for early detection of chikungunya virus.

Keywords

Chikungunya, IgM antibodies, Sero-prevalence

Introduction

Chikungunya is a self-remitting febrile viral disease which is transmitted to humans by infected Aedes mosquitoes. The name chikungunya refers to the 'stooped' appearance of those suffering from severe joint pain. It usually presented with fever and joint pains with chills, vomiting, nausea, headache and rashes [1]. It affects humans of all age especially in post monsoon season and is listed as category C priority pathogen under US National Institute of Allergy and Infectious Diseases (NIAID) [2] CHIKV was first detected in 1963 in West Bengal followed by epidemics in eastern coastal areas [3,4]. The disease was on decline as only few outbreaks were seen till 1973 and after this no cases were reported for over a period of 30 years. It reappeared in 2005 in the state of Andrapradesh and has spread to the whole country affecting millions [5]. The viral illness has many similarities to dengue viral illness and presence of Dengue epidemic in a country like ours it remains underdiagnosed. The present study aims to highlight the prevalence of Chikungunya in Central India.

Materials and Methods

The retrospective study was conducted department of Microbiology MGM Medical College and M.Y. Hospital, Indore from January 2017 to December 2017. All serum samples were received with details Patients, Clinical finding and investigation of patients from various districts of the state from January 2017 to December 2017 were included in the study. About 5–10 ml of whole blood sample was collected after 5 days of suspected Viral fever and transported by the staff of the medical college, district headquarters and other hospitals to the department of microbiology in an ice box maintained at 2–8?C temperature within 24–48 hours serum was separated from whole blood by centrifugation and stored at −20 °C. The samples were tested for CHIK Immunoglobin M (IgM) antibodies by enzymelinked immunosorbent assay.(NIV Chikungunya IgM Capture ELISA Kit, Manufacturer: National Institute of Virology, Pune ). The sensitivity and specificity for chikungunya IgM antibody capture ELISA are 95.00% and 98.00% respectively. All assays were performed according to the manufacturers’ procedures.

Results

A total of 245 serum samples from suspected cases of Chikungunya infection were received during the period from January 2017 to December 2017, out of which 188 (76.7%) samples were positive for CHIK (Table 1).

Total samples tested 245
Positive 188 (76.7%)
Negative 57 (23.3%)

Table 1. Seroprevalence of Chikungunya in the patients of central India.

Males were predominantly affected as 104 (55.3%) (Table 2). Most common seropositive age group was 41 to 50 year as 32 (17%) and least common was 81-90 years (1.1%) (Table 3). The chikungunya infection was highest from Indore district as 147(78.2 %) followed by Khargone 17 (9%), Khandwa 9 (4.8%), Barwani 5 (2.7%), Dhar 4 (2.1%), Jhabua 3 (1.6%) and Mandsaur 3 (1.6%) (Table 4). A seasonal peak for chikungunya was seen in the month of October as 82 (43.6%) (Table 5).

Gender Positive Negative
Male 104 28
Female 84 29

Table 2. Gender based distribution of Chikungunya cases.

   Age
0-1 1-10 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90
Positive 7 (3.7) 18 (9.6) 15 (8) 23 (12.2) 29 (15.4) 32 (17) 28 (14.9) 18 (9.6) 16 (8.5) 2 (1.1)
Negative 0 (0) 4(7) 10 (17.5) 8 (14) 9 (15.8) 9 (15.8) 10 (17.5) 4(7) 3 (5.2) 0 (0)

Table 3. Age wise distribution of chikungunya cases.

  District
  Indore Barwani Khargone Khandwa Dhar Jhabua Mandsaur
Positive 147(78.2) 5 (2.7) 17 (9) 9 (4.8) 4(2.1) 3 (1.6) 3 (1.6)
Negative 21 7 (12.3) 12 (21.1) 6 (10.5) 9(15.8) 2 (3.5) 0 (0)

Table 4. District wise distribution of chikungunya cases.

 MONTHS
  JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC
Positive 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 2 (1.06) 42 (22.3) 33 (17.6) 82 (43.6) 26 (13.8) 3 (1.6)
Negative 0(0) 0(0) 0(0) 0(0) 1 (1.8) 0(0) 0(0) 22 (38.6) 14 (24.6) 12 (21.1) 6 (10.5) 2 (3.51)

Table 5. Seasonal distribution of Chikungunya seropositive cases.

Discussion

Arboviral infections are an important public health problem in India namely dengue and chikungunya. The Aedes mosquitoborne Chikungunya virus (CHIKV) is an enveloped, linear, single stranded positive sense RNA virus of the family Togaviridae transmitted in India, primarily by Aedes et al. [6,7]. The serosurvey conducted in Kolkata in 1994 showed sero-positivity only in 4.37% of the samples whereas cross-sectional study done in Anagaputhur in 2006 showed around 22.3% positivity [8,9]. In another study by Chatopaddhayay in 2016, seroprevalence was found to be 36.89% [10]. The seroprevelance of chikungunya cases in our study was 76.7% which is comparatively higher compared to the other studies. The maximum number of positive cases was seen in 41-50 years age group followed by 31-40 years of age group. Children were least affected in this study. These are consistent with the findings reported by Cordel et al [11]. However, in another study conducted by Sharma et al., it was found that the population belonging to the age group 5–9 years had the highest percentage of morbidity (23.2%). The lowest percentage of morbidity was reported among infants (8.9%) [12].

In the present study, sero-positivity was more in males compared to females which is consistent with the findings of Sharma et al., it has been reported that the males were more frequently affected than females.[12] However in the study conducted by Balasubramaniam et al; females had more seropositivity compared to males. [9] Chikungunya is a disease of post monsoon season and authors found highest seroprevalence in the month of October followed by August comparable to the other studies were peak incidence was found in the month of August and September [10].

This suggests that this disease is not limited in the post monsoon season but covers both monsoon and post monsoon season as in our study the cases are seen from the month of July to December. This season corresponds with the presence of dengue in the community. There clinical presentation is similar and dengue chikungunya infection has been found to co-exist. Many cases of acute febrile diseases due to chikungunya are underdiagnosed and the circulation of these disease-causing arbo viruses may be much greater than reported. The clinicians need to be made aware of the re-emergence of Chikungunya in the community and simultaneously chikungunya should be investigated as a differential of Dengue fever. The present study indicates that the chikungunya infection has emerged as a major public threat in our community.

Conclusion

Continuous sero-surveillance needs to be maintained in outbreak and non-outbreak areas to have the baseline data in apparent CHIK infections. In addition, extra effort needs to be directed to find more cases in patients with Dengue sero positivity to understand the complete burden of the diseases.

Conflicts of Interest

None.

References

Author Info

Suneel Kumar*

MGM Medical College, Indore, India
 

Citation: Suneel Kumar,Seroprevalence of Chikungunya Virus from a Tertiary Care Hospital of Central India-A Major Public Health Problem, J Res Med Dent Sci, 2021, 9(10): 12-14

Received Date: Aug 16, 2021 / Accepted Date: Sep 16, 2021 /

cappadocia tours
cappadocia hotels
cappadocia balloon flights

paper.io

agar io

wormax io